Changes of plasma endothelin and growth factor levels, and of left ventricular mass, after chronic AT1-receptor blockade in human hypertension

American Journal of Hypertension

Volumn 11, Issue 5, 1998, Pages 548-553

  Cottone, Santina ^a,b   Vadalà, Anna ^a   Vella, Maria C ^a   Nardi, Emilio ^a   Mulé, Giuseppe ^a   Contorno, Antonino ^a   Riccobene, Raffaella ^a   Cerasola, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Angiotensin receptors; Ethelin 1; Growth factors; Hypertension; Losartan

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIN 1; LOSARTAN; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE MASS; HORMONAL REGULATION; HUMAN; MALE; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; ENDOTHELINS; FEMALE; GROWTH SUBSTANCES; HEART VENTRICLES; HUMANS; HYPERTENSION; LOSARTAN; MALE; MYOCARDIUM; RECEPTORS, ANGIOTENSIN;

EID: 0031811784     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00027-2     Document Type: Article

References (23)

1. Campbell DJ: Circulating and tissue angiotensin systems. J Clin Invest 1987;79:1-6.
2. Dzau VJ: Cell biology and genetics of angiotensin in cardiovascular disease. J Hypertens 1994;12 (suppl 4): S3-S10.
3. Fyhrquist F, Metsarinne K, Tikkanen I: Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. J Hum Hypertens 1995;9 (suppl 5):S19-S24.
4. Fischer T, Ungureanu-Longrois D, Singh K, et al: Regulation of basic fibroblast growth factor expression and angiotensin II secretion in cardiac myocytes and microvascular endothelial cell. Am J Physiol 1997;272:H958-H968.
5. Bilato C, Pauly RR, Melillo G, et al: Intracellular signaling pathways required for vascular smooth muscle cell. Interaction between bfibroblast growth factor and platelet derived growth factor. J Clin Invest 1995;96: 1905-1915.
6. Bonner JC, Badgett A, Lindroos PM, Coin PG: Basic fibroblast growth factor induces expression of the PDGF receptor alpha on human bronchial smooth muscle cell. Am J Physiol 1996;271:L880-L888.
7. Masaki T: Endothelins: homeostatic and compensatory actions in the circulatory and endocrine system. Endocrine Rev 1993;14:256-268.
8. Ito H, Hirata Y, Adachi S, et al: Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 1993;92:398-403.
9. Bakris GL, Re RN: Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am J Physiol 1993;264:F937-F942.
10. Morton JJ, Beattie EC, MacPherson F: Treatment of young spontaneously hypertensive rats with angiotensin receptor antagonist losartan reduced hypertension and vascular hypertrophy in adulthood. J Hypertens 1992;10 (suppl 4):S151-S153.
11. Oddie CJ, Dilley RJ, Bobik A: Long-term angiotensin II antagonist in spontaneously hypertensive rats: effect on blood pressure and cardiovascular amplifiers. Clin Exp Pharm Physiol 1992;19:392-395.
12. Himmelmann A, Svensson A, Dahlof B, et al: Losartan in essential hypertension: effects on blood pressure and left ventricular mass. High Blood Pressure 1995;4:242-248.
13. Sahn DJ, De Maria A, Kisslo J, et al: The Committee on M-Mode Standardization of the American Society of Echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
14. Crowley ST, Ray CJ, Nawaz D, et al: Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol 1995;269:H1641-H1647.
15. Yoshizumi M, Kurihara H, Sugiyama T, et al: Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989;160:93-100.
16. Morita T, Kurihara H, Maemura K, et al: Disruption of cytoskeletal structures mediates shear stress induced endothelin 1 gene expression in cultured porcine aortic endothelial cells. J Clin Invest 1993;92:1706-1712.
17. Malek AM, Greene AL, Izumo S: Regulation of endothelin 1 gene by fluid shear stress is trascriptionally mediated and independent of protein kinase C and cyclic AMP. Proc Natl Acad Sci USA 1993;90:5999-6003.
18. Malek A, Gibbons M, Dzau VJ, et al: Fluid shear stress differentially modulates expression of genes encoding basic FGF and PDGF-beta chain in vascular endothelium. J Clin Invest 1993;92:2013-2021.
19. Barbagallo M, Gupta RK, Resnick LM: Cellular ions in NIDDM: relation of calcium to hyperglicemia and cardiac mass. Diabetes Care 1996;19:1393-1398.
20. Linz W, Henning R, Scholkens BA: ACE inhibition and angiotensin II receptor antagonism on development and regression of cardiac hypertrophy in rats J Hypertens 1991;9 (suppl 6):S400-S401.
21. Dostal DE, Baker KM: Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart: mediation by the AT1 receptor. Am J Hypertens 1992;5:276-280.
22. Quing G, Garcia R: Chronic captopril and losartan (DuP753) administration in rats with high-output heart failure. Am J Physiol 1992;263:H833-H840.
23. Everett AD, Tufro-McReddie A, Fischer A, et al: Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-B1 expression. Hypertension 1994;23:587-592.